nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—Small Ligand GPCRs—MTNR1A—type 2 diabetes mellitus	0.0246	0.0862	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—S100A6—type 2 diabetes mellitus	0.0237	0.0827	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGDS—type 2 diabetes mellitus	0.0189	0.0661	CbGpPWpGaD
Travoprost—PTGFR—Small Ligand GPCRs—MTNR1B—type 2 diabetes mellitus	0.0129	0.0453	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—HSD11B1—type 2 diabetes mellitus	0.0116	0.0404	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—CYP11A1—type 2 diabetes mellitus	0.00775	0.0271	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDNRB—type 2 diabetes mellitus	0.00721	0.0252	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDNRA—type 2 diabetes mellitus	0.00681	0.0238	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—type 2 diabetes mellitus	0.00491	0.0172	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GCGR—type 2 diabetes mellitus	0.00341	0.0119	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GRK5—type 2 diabetes mellitus	0.00314	0.011	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MTNR1A—type 2 diabetes mellitus	0.00306	0.0107	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GCGR—type 2 diabetes mellitus	0.00305	0.0107	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—type 2 diabetes mellitus	0.00281	0.00983	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—EDNRA—type 2 diabetes mellitus	0.0028	0.0098	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—type 2 diabetes mellitus	0.00273	0.00956	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.00262	0.00916	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.00222	0.00777	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00199	0.00698	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—CCKAR—type 2 diabetes mellitus	0.00199	0.00697	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.0019	0.00666	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.00182	0.00636	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CCR5—type 2 diabetes mellitus	0.00181	0.00631	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.00178	0.00623	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.00175	0.00613	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00172	0.00602	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.00167	0.00583	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	0.00162	0.00566	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.00161	0.00562	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00158	0.00554	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	0.00157	0.00551	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	0.00157	0.00548	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.00156	0.00545	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.00154	0.00539	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	0.00153	0.00537	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	0.00149	0.00522	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.00145	0.00507	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	0.00145	0.00506	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	0.00141	0.00493	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	0.0014	0.00491	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.0014	0.00488	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	0.00138	0.00483	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00138	0.00481	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.00137	0.0048	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.00135	0.00471	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00132	0.00461	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.00129	0.00451	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.00126	0.00439	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.00125	0.00438	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.00124	0.00432	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.00122	0.00426	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.00121	0.00423	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.00119	0.00417	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.00119	0.00417	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.00119	0.00415	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.00115	0.00403	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00115	0.00401	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.00114	0.00397	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00113	0.00394	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.0011	0.00386	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.00108	0.00378	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00107	0.00375	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.00107	0.00373	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.00107	0.00373	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00105	0.00366	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00104	0.00365	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00102	0.00358	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00102	0.00357	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00102	0.00357	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00102	0.00355	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.00102	0.00355	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.001	0.00351	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.000973	0.0034	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	0.000942	0.0033	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000905	0.00316	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.000896	0.00313	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.000896	0.00313	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000884	0.00309	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000878	0.00307	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.000843	0.00295	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000841	0.00294	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000837	0.00293	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.000819	0.00286	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000816	0.00286	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000813	0.00284	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000813	0.00284	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000794	0.00278	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.00079	0.00276	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.000788	0.00276	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.000784	0.00274	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000777	0.00272	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000774	0.00271	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000765	0.00268	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000764	0.00267	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000752	0.00263	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000744	0.0026	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000716	0.0025	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000708	0.00248	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000692	0.00242	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000672	0.00235	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.00067	0.00234	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000657	0.0023	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000648	0.00226	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000624	0.00218	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000619	0.00216	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.00061	0.00213	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000609	0.00213	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000605	0.00212	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000602	0.0021	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000592	0.00207	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000588	0.00206	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000577	0.00202	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000572	0.002	CbGpPWpGaD
Travoprost—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000571	0.0008	CcSEcCtD
Travoprost—Discomfort—Orlistat—type 2 diabetes mellitus	0.00057	0.000799	CcSEcCtD
Travoprost—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000569	0.000798	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000568	0.00199	CbGpPWpGaD
Travoprost—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000564	0.000791	CcSEcCtD
Travoprost—Malaise—Metformin—type 2 diabetes mellitus	0.000563	0.000789	CcSEcCtD
Travoprost—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000563	0.000789	CcSEcCtD
Travoprost—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000561	0.000786	CcSEcCtD
Travoprost—Oedema—Valsartan—type 2 diabetes mellitus	0.00056	0.000784	CcSEcCtD
Travoprost—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000559	0.000784	CcSEcCtD
Travoprost—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000559	0.000783	CcSEcCtD
Travoprost—Infection—Valsartan—type 2 diabetes mellitus	0.000556	0.000779	CcSEcCtD
Travoprost—Rash—Glipizide—type 2 diabetes mellitus	0.000556	0.000779	CcSEcCtD
Travoprost—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000556	0.000779	CcSEcCtD
Travoprost—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000555	0.000778	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000555	0.000778	CcSEcCtD
Travoprost—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000555	0.000778	CcSEcCtD
Travoprost—Erythema—Losartan—type 2 diabetes mellitus	0.000555	0.000777	CcSEcCtD
Travoprost—Oedema—Orlistat—type 2 diabetes mellitus	0.000553	0.000775	CcSEcCtD
Travoprost—Headache—Glipizide—type 2 diabetes mellitus	0.000552	0.000774	CcSEcCtD
Travoprost—Palpitations—Metformin—type 2 diabetes mellitus	0.000552	0.000774	CcSEcCtD
Travoprost—Infection—Orlistat—type 2 diabetes mellitus	0.00055	0.00077	CcSEcCtD
Travoprost—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000549	0.000769	CcSEcCtD
Travoprost—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000547	0.000766	CcSEcCtD
Travoprost—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000544	0.000762	CcSEcCtD
Travoprost—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000544	0.000762	CcSEcCtD
Travoprost—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000543	0.000761	CcSEcCtD
Travoprost—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000543	0.000761	CcSEcCtD
Travoprost—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000542	0.00076	CcSEcCtD
Travoprost—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000542	0.00076	CcSEcCtD
Travoprost—Hypertension—Metformin—type 2 diabetes mellitus	0.000539	0.000756	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000538	0.00188	CbGpPWpGaD
Travoprost—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000537	0.000753	CcSEcCtD
Travoprost—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000537	0.000752	CcSEcCtD
Travoprost—Back pain—Losartan—type 2 diabetes mellitus	0.000537	0.000752	CcSEcCtD
Travoprost—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000536	0.000752	CcSEcCtD
Travoprost—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000536	0.000752	CcSEcCtD
Travoprost—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000533	0.000746	CcSEcCtD
Travoprost—Chest pain—Metformin—type 2 diabetes mellitus	0.000532	0.000745	CcSEcCtD
Travoprost—Myalgia—Metformin—type 2 diabetes mellitus	0.000532	0.000745	CcSEcCtD
Travoprost—Malaise—Irbesartan—type 2 diabetes mellitus	0.000532	0.000745	CcSEcCtD
Travoprost—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00053	0.000742	CcSEcCtD
Travoprost—Headache—Pioglitazone—type 2 diabetes mellitus	0.000529	0.000742	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000528	0.00074	CcSEcCtD
Travoprost—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000527	0.000738	CcSEcCtD
Travoprost—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000526	0.000737	CcSEcCtD
Travoprost—Discomfort—Metformin—type 2 diabetes mellitus	0.000525	0.000736	CcSEcCtD
Travoprost—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000525	0.000736	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000524	0.00183	CbGpPWpGaD
Travoprost—Nausea—Glipizide—type 2 diabetes mellitus	0.000524	0.000734	CcSEcCtD
Travoprost—Hypotension—Valsartan—type 2 diabetes mellitus	0.000523	0.000733	CcSEcCtD
Travoprost—Vision blurred—Losartan—type 2 diabetes mellitus	0.000523	0.000733	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000522	0.00183	CbGpPWpGaD
Travoprost—Pain—Gliclazide—type 2 diabetes mellitus	0.000521	0.00073	CcSEcCtD
Travoprost—Constipation—Gliclazide—type 2 diabetes mellitus	0.000521	0.00073	CcSEcCtD
Travoprost—Rash—Glimepiride—type 2 diabetes mellitus	0.000519	0.000727	CcSEcCtD
Travoprost—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000518	0.000726	CcSEcCtD
Travoprost—Rash—Sitagliptin—type 2 diabetes mellitus	0.000517	0.000725	CcSEcCtD
Travoprost—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000517	0.000724	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000516	0.0018	CbGpPWpGaD
Travoprost—Headache—Glimepiride—type 2 diabetes mellitus	0.000515	0.000722	CcSEcCtD
Travoprost—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000515	0.000721	CcSEcCtD
Travoprost—Cough—Irbesartan—type 2 diabetes mellitus	0.000514	0.000721	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000514	0.0018	CbGpPWpGaD
Travoprost—Headache—Sitagliptin—type 2 diabetes mellitus	0.000514	0.00072	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000512	0.00179	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000511	0.00179	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00051	0.000715	CcSEcCtD
Travoprost—Oedema—Metformin—type 2 diabetes mellitus	0.00051	0.000714	CcSEcCtD
Travoprost—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000509	0.000714	CcSEcCtD
Travoprost—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000509	0.000713	CcSEcCtD
Travoprost—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000508	0.000712	CcSEcCtD
Travoprost—Infection—Metformin—type 2 diabetes mellitus	0.000506	0.00071	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000504	0.000706	CcSEcCtD
Travoprost—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000502	0.000704	CcSEcCtD
Travoprost—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000502	0.000703	CcSEcCtD
Travoprost—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000502	0.000703	CcSEcCtD
Travoprost—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000502	0.000703	CcSEcCtD
Travoprost—Malaise—Losartan—type 2 diabetes mellitus	0.0005	0.000701	CcSEcCtD
Travoprost—Anxiety—Irbesartan—type 2 diabetes mellitus	0.0005	0.000701	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—C3—type 2 diabetes mellitus	0.0005	0.00175	CbGpPWpGaD
Travoprost—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0005	0.000701	CcSEcCtD
Travoprost—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.0005	0.000701	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000499	0.00175	CbGpPWpGaD
Travoprost—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000499	0.000699	CcSEcCtD
Travoprost—Vertigo—Losartan—type 2 diabetes mellitus	0.000498	0.000698	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000498	0.000698	CcSEcCtD
Travoprost—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000498	0.000698	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000496	0.00174	CbGpPWpGaD
Travoprost—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000496	0.000695	CcSEcCtD
Travoprost—Skin disorder—Metformin—type 2 diabetes mellitus	0.000495	0.000694	CcSEcCtD
Travoprost—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000494	0.000692	CcSEcCtD
Travoprost—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000493	0.000691	CcSEcCtD
Travoprost—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000492	0.00069	CcSEcCtD
Travoprost—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000491	0.000688	CcSEcCtD
Travoprost—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000491	0.000688	CcSEcCtD
Travoprost—Palpitations—Losartan—type 2 diabetes mellitus	0.00049	0.000687	CcSEcCtD
Travoprost—Nausea—Glimepiride—type 2 diabetes mellitus	0.000489	0.000685	CcSEcCtD
Travoprost—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000487	0.000683	CcSEcCtD
Travoprost—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000487	0.000682	CcSEcCtD
Travoprost—Asthenia—Glyburide—type 2 diabetes mellitus	0.000487	0.000682	CcSEcCtD
Travoprost—Cough—Losartan—type 2 diabetes mellitus	0.000484	0.000678	CcSEcCtD
Travoprost—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000483	0.000677	CcSEcCtD
Travoprost—Fatigue—Valsartan—type 2 diabetes mellitus	0.000483	0.000676	CcSEcCtD
Travoprost—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000482	0.000675	CcSEcCtD
Travoprost—Oedema—Irbesartan—type 2 diabetes mellitus	0.000481	0.000674	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.00048	0.00168	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.00048	0.00168	CbGpPWpGaD
Travoprost—Pruritus—Glyburide—type 2 diabetes mellitus	0.00048	0.000673	CcSEcCtD
Travoprost—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000479	0.000671	CcSEcCtD
Travoprost—Constipation—Valsartan—type 2 diabetes mellitus	0.000479	0.000671	CcSEcCtD
Travoprost—Infection—Irbesartan—type 2 diabetes mellitus	0.000478	0.00067	CcSEcCtD
Travoprost—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000478	0.000669	CcSEcCtD
Travoprost—Fatigue—Orlistat—type 2 diabetes mellitus	0.000477	0.000668	CcSEcCtD
Travoprost—Hypotension—Metformin—type 2 diabetes mellitus	0.000476	0.000668	CcSEcCtD
Travoprost—Erythema—Ramipril—type 2 diabetes mellitus	0.000476	0.000667	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000475	0.00166	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000475	0.00166	CbGpPWpGaD
Travoprost—Pain—Orlistat—type 2 diabetes mellitus	0.000473	0.000663	CcSEcCtD
Travoprost—Chest pain—Losartan—type 2 diabetes mellitus	0.000472	0.000662	CcSEcCtD
Travoprost—Myalgia—Losartan—type 2 diabetes mellitus	0.000472	0.000662	CcSEcCtD
Travoprost—Arthralgia—Losartan—type 2 diabetes mellitus	0.000472	0.000662	CcSEcCtD
Travoprost—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000472	0.000661	CcSEcCtD
Travoprost—Anxiety—Losartan—type 2 diabetes mellitus	0.000471	0.00066	CcSEcCtD
Travoprost—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00047	0.000658	CcSEcCtD
Travoprost—Rash—Bromocriptine—type 2 diabetes mellitus	0.000468	0.000656	CcSEcCtD
Travoprost—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000468	0.000655	CcSEcCtD
Travoprost—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000467	0.000655	CcSEcCtD
Travoprost—Discomfort—Losartan—type 2 diabetes mellitus	0.000467	0.000654	CcSEcCtD
Travoprost—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000466	0.000653	CcSEcCtD
Travoprost—Headache—Bromocriptine—type 2 diabetes mellitus	0.000465	0.000652	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000464	0.000651	CcSEcCtD
Travoprost—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000464	0.000651	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000464	0.00162	CbGpPWpGaD
Travoprost—Dry mouth—Losartan—type 2 diabetes mellitus	0.000462	0.000647	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000461	0.00161	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000458	0.000641	CcSEcCtD
Travoprost—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000456	0.000639	CcSEcCtD
Travoprost—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000455	0.000637	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000453	0.00159	CbGpPWpGaD
Travoprost—Oedema—Losartan—type 2 diabetes mellitus	0.000453	0.000634	CcSEcCtD
Travoprost—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000452	0.000634	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000451	0.00158	CbGpPWpGaD
Travoprost—Infection—Losartan—type 2 diabetes mellitus	0.00045	0.00063	CcSEcCtD
Travoprost—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00045	0.00063	CcSEcCtD
Travoprost—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000449	0.000629	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000449	0.00157	CbGpPWpGaD
Travoprost—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000449	0.000629	CcSEcCtD
Travoprost—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000444	0.000622	CcSEcCtD
Travoprost—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000443	0.00062	CcSEcCtD
Travoprost—Tachycardia—Losartan—type 2 diabetes mellitus	0.000442	0.000619	CcSEcCtD
Travoprost—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000441	0.000618	CcSEcCtD
Travoprost—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000441	0.000618	CcSEcCtD
Travoprost—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00044	0.000617	CcSEcCtD
Travoprost—Fatigue—Metformin—type 2 diabetes mellitus	0.00044	0.000616	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000439	0.00154	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000439	0.00154	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000438	0.000614	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000437	0.00153	CbGpPWpGaD
Travoprost—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000437	0.000613	CcSEcCtD
Travoprost—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000437	0.000613	CcSEcCtD
Travoprost—Constipation—Metformin—type 2 diabetes mellitus	0.000436	0.000611	CcSEcCtD
Travoprost—Tafluprost—PTGS2—type 2 diabetes mellitus	0.000434	1	CrCbGaD
Travoprost—PTGFR—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000432	0.00151	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000432	0.00151	CbGpPWpGaD
Travoprost—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000431	0.000604	CcSEcCtD
Travoprost—Malaise—Ramipril—type 2 diabetes mellitus	0.000429	0.000601	CcSEcCtD
Travoprost—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000429	0.000601	CcSEcCtD
Travoprost—Rash—Glyburide—type 2 diabetes mellitus	0.000428	0.0006	CcSEcCtD
Travoprost—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000427	0.000599	CcSEcCtD
Travoprost—Vertigo—Ramipril—type 2 diabetes mellitus	0.000427	0.000599	CcSEcCtD
Travoprost—Headache—Glyburide—type 2 diabetes mellitus	0.000425	0.000596	CcSEcCtD
Travoprost—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000424	0.000593	CcSEcCtD
Travoprost—Hypotension—Losartan—type 2 diabetes mellitus	0.000423	0.000593	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000423	0.00148	CbGpPWpGaD
Travoprost—Palpitations—Ramipril—type 2 diabetes mellitus	0.00042	0.000589	CcSEcCtD
Travoprost—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00042	0.000589	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000419	0.00147	CbGpPWpGaD
Travoprost—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000417	0.000584	CcSEcCtD
Travoprost—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000417	0.000584	CcSEcCtD
Travoprost—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000415	0.000582	CcSEcCtD
Travoprost—Cough—Ramipril—type 2 diabetes mellitus	0.000415	0.000582	CcSEcCtD
Travoprost—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000415	0.000581	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000413	0.000578	CcSEcCtD
Travoprost—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000412	0.000578	CcSEcCtD
Travoprost—Constipation—Irbesartan—type 2 diabetes mellitus	0.000411	0.000577	CcSEcCtD
Travoprost—Pain—Irbesartan—type 2 diabetes mellitus	0.000411	0.000577	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000408	0.00143	CbGpPWpGaD
Travoprost—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000408	0.000571	CcSEcCtD
Travoprost—Chest pain—Ramipril—type 2 diabetes mellitus	0.000405	0.000568	CcSEcCtD
Travoprost—Myalgia—Ramipril—type 2 diabetes mellitus	0.000405	0.000568	CcSEcCtD
Travoprost—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000405	0.000568	CcSEcCtD
Travoprost—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000404	0.000566	CcSEcCtD
Travoprost—Anxiety—Ramipril—type 2 diabetes mellitus	0.000404	0.000566	CcSEcCtD
Travoprost—Nausea—Glyburide—type 2 diabetes mellitus	0.000403	0.000565	CcSEcCtD
Travoprost—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000403	0.000565	CcSEcCtD
Travoprost—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000403	0.000565	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000402	0.000564	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000402	0.00141	CbGpPWpGaD
Travoprost—Asthenia—Valsartan—type 2 diabetes mellitus	0.000402	0.000563	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000401	0.0014	CbGpPWpGaD
Travoprost—Discomfort—Ramipril—type 2 diabetes mellitus	0.0004	0.000561	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.0004	0.0014	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000399	0.00139	CbGpPWpGaD
Travoprost—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000399	0.000558	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000397	0.00139	CbGpPWpGaD
Travoprost—Asthenia—Orlistat—type 2 diabetes mellitus	0.000397	0.000556	CcSEcCtD
Travoprost—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000396	0.000556	CcSEcCtD
Travoprost—Pruritus—Valsartan—type 2 diabetes mellitus	0.000396	0.000555	CcSEcCtD
Travoprost—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000396	0.000555	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000394	0.00138	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000393	0.000551	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000392	0.00137	CbGpPWpGaD
Travoprost—Pruritus—Orlistat—type 2 diabetes mellitus	0.000391	0.000548	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000391	0.00137	CbGpPWpGaD
Travoprost—Fatigue—Losartan—type 2 diabetes mellitus	0.00039	0.000547	CcSEcCtD
Travoprost—Oedema—Ramipril—type 2 diabetes mellitus	0.000388	0.000544	CcSEcCtD
Travoprost—Pain—Losartan—type 2 diabetes mellitus	0.000387	0.000543	CcSEcCtD
Travoprost—Constipation—Losartan—type 2 diabetes mellitus	0.000387	0.000543	CcSEcCtD
Travoprost—Rash—Gliclazide—type 2 diabetes mellitus	0.000384	0.000538	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000384	0.00134	CbGpPWpGaD
Travoprost—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000384	0.000538	CcSEcCtD
Travoprost—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000383	0.000537	CcSEcCtD
Travoprost—Headache—Gliclazide—type 2 diabetes mellitus	0.000382	0.000535	CcSEcCtD
Travoprost—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000381	0.000534	CcSEcCtD
Travoprost—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00038	0.000533	CcSEcCtD
Travoprost—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000379	0.000531	CcSEcCtD
Travoprost—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000378	0.00053	CcSEcCtD
Travoprost—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000377	0.000528	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000374	0.00131	CbGpPWpGaD
Travoprost—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000373	0.000523	CcSEcCtD
Travoprost—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00037	0.000519	CcSEcCtD
Travoprost—Dizziness—Valsartan—type 2 diabetes mellitus	0.00037	0.000519	CcSEcCtD
Travoprost—Dizziness—Orlistat—type 2 diabetes mellitus	0.000366	0.000513	CcSEcCtD
Travoprost—Asthenia—Metformin—type 2 diabetes mellitus	0.000366	0.000513	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000363	0.00127	CbGpPWpGaD
Travoprost—Hypotension—Ramipril—type 2 diabetes mellitus	0.000363	0.000508	CcSEcCtD
Travoprost—Nausea—Gliclazide—type 2 diabetes mellitus	0.000362	0.000507	CcSEcCtD
Travoprost—Pruritus—Metformin—type 2 diabetes mellitus	0.000361	0.000505	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.00036	0.00126	CbGpPWpGaD
Travoprost—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000358	0.000502	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000357	0.00125	CbGpPWpGaD
Travoprost—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000354	0.000497	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000354	0.000496	CcSEcCtD
Travoprost—Rash—Valsartan—type 2 diabetes mellitus	0.000353	0.000495	CcSEcCtD
Travoprost—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000353	0.000494	CcSEcCtD
Travoprost—Headache—Valsartan—type 2 diabetes mellitus	0.000351	0.000491	CcSEcCtD
Travoprost—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000349	0.000489	CcSEcCtD
Travoprost—Rash—Orlistat—type 2 diabetes mellitus	0.000349	0.000489	CcSEcCtD
Travoprost—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000348	0.000488	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000347	0.00121	CbGpPWpGaD
Travoprost—Headache—Orlistat—type 2 diabetes mellitus	0.000347	0.000486	CcSEcCtD
Travoprost—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000346	0.000485	CcSEcCtD
Travoprost—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000345	0.000484	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000345	0.00121	CbGpPWpGaD
Travoprost—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000342	0.000479	CcSEcCtD
Travoprost—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00034	0.000477	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.00034	0.00119	CbGpPWpGaD
Travoprost—Dizziness—Metformin—type 2 diabetes mellitus	0.000337	0.000472	CcSEcCtD
Travoprost—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000335	0.00047	CcSEcCtD
Travoprost—Fatigue—Ramipril—type 2 diabetes mellitus	0.000335	0.000469	CcSEcCtD
Travoprost—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000334	0.000467	CcSEcCtD
Travoprost—Nausea—Valsartan—type 2 diabetes mellitus	0.000333	0.000466	CcSEcCtD
Travoprost—Constipation—Ramipril—type 2 diabetes mellitus	0.000332	0.000465	CcSEcCtD
Travoprost—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000329	0.000461	CcSEcCtD
Travoprost—Nausea—Orlistat—type 2 diabetes mellitus	0.000329	0.00046	CcSEcCtD
Travoprost—Asthenia—Losartan—type 2 diabetes mellitus	0.000325	0.000455	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000324	0.00113	CbGpPWpGaD
Travoprost—Rash—Metformin—type 2 diabetes mellitus	0.000321	0.00045	CcSEcCtD
Travoprost—Dermatitis—Metformin—type 2 diabetes mellitus	0.000321	0.00045	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000321	0.00112	CbGpPWpGaD
Travoprost—Pruritus—Losartan—type 2 diabetes mellitus	0.00032	0.000449	CcSEcCtD
Travoprost—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00032	0.000448	CcSEcCtD
Travoprost—Headache—Metformin—type 2 diabetes mellitus	0.000319	0.000448	CcSEcCtD
Travoprost—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000318	0.000446	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000318	0.00111	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000318	0.00111	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000317	0.000445	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000313	0.00109	CbGpPWpGaD
Travoprost—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00031	0.000434	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00031	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00031	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000309	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000309	0.00108	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000308	0.00108	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000307	0.00107	CbGpPWpGaD
Travoprost—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000307	0.00043	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000305	0.00107	CbGpPWpGaD
Travoprost—Rash—Irbesartan—type 2 diabetes mellitus	0.000303	0.000425	CcSEcCtD
Travoprost—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000303	0.000425	CcSEcCtD
Travoprost—Nausea—Metformin—type 2 diabetes mellitus	0.000303	0.000424	CcSEcCtD
Travoprost—Headache—Irbesartan—type 2 diabetes mellitus	0.000301	0.000422	CcSEcCtD
Travoprost—Dizziness—Losartan—type 2 diabetes mellitus	0.000299	0.00042	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000294	0.00103	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000289	0.00101	CbGpPWpGaD
Travoprost—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000286	0.000401	CcSEcCtD
Travoprost—Nausea—Irbesartan—type 2 diabetes mellitus	0.000286	0.0004	CcSEcCtD
Travoprost—Rash—Losartan—type 2 diabetes mellitus	0.000285	0.0004	CcSEcCtD
Travoprost—Dermatitis—Losartan—type 2 diabetes mellitus	0.000285	0.0004	CcSEcCtD
Travoprost—Headache—Losartan—type 2 diabetes mellitus	0.000284	0.000397	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000283	0.000988	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000279	0.000976	CbGpPWpGaD
Travoprost—Asthenia—Ramipril—type 2 diabetes mellitus	0.000279	0.00039	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000276	0.000965	CbGpPWpGaD
Travoprost—Pruritus—Ramipril—type 2 diabetes mellitus	0.000275	0.000385	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000274	0.000959	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000273	0.000953	CbGpPWpGaD
Travoprost—Nausea—Losartan—type 2 diabetes mellitus	0.000269	0.000377	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000269	0.000939	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000268	0.000936	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000267	0.000935	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000266	0.000931	CbGpPWpGaD
Travoprost—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000266	0.000372	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000263	0.000919	CbGpPWpGaD
Travoprost—Dizziness—Ramipril—type 2 diabetes mellitus	0.000257	0.00036	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000257	0.000898	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000255	0.000892	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000248	0.000868	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000248	0.000866	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000248	0.000866	CbGpPWpGaD
Travoprost—Rash—Ramipril—type 2 diabetes mellitus	0.000245	0.000343	CcSEcCtD
Travoprost—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000245	0.000343	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000244	0.000853	CbGpPWpGaD
Travoprost—Headache—Ramipril—type 2 diabetes mellitus	0.000243	0.000341	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000241	0.000842	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00024	0.000839	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00024	0.000838	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000236	0.000824	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000235	0.000821	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000235	0.000821	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000232	0.000811	CbGpPWpGaD
Travoprost—Nausea—Ramipril—type 2 diabetes mellitus	0.000231	0.000323	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000225	0.000788	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000218	0.000763	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000217	0.00076	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000215	0.000751	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000215	0.000751	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000211	0.000738	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.00021	0.000736	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000201	0.000702	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000197	0.00069	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000197	0.000689	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000187	0.000653	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000185	0.000647	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000182	0.000638	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000182	0.000638	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000182	0.000635	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000181	0.000633	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000179	0.000626	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000176	0.000617	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000176	0.000614	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000174	0.000607	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000168	0.000589	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000165	0.000577	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000158	0.000553	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000155	0.000543	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—C3—type 2 diabetes mellitus	0.000152	0.00053	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000145	0.000506	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000144	0.000504	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000144	0.000504	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000142	0.000495	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000141	0.000494	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000141	0.000494	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.00014	0.000488	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000133	0.000466	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000126	0.00044	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—INS—type 2 diabetes mellitus	0.000121	0.000422	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000119	0.000415	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000117	0.000408	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000117	0.000408	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000116	0.000406	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000111	0.000387	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000106	0.00037	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000106	0.00037	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	9.95e-05	0.000348	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.06e-05	0.000317	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.98e-05	0.000314	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.92e-05	0.000312	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.48e-05	0.000297	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.39e-05	0.000294	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.23e-05	0.000288	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	7.82e-05	0.000274	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.62e-05	0.000266	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.99e-05	0.000245	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.86e-05	0.00024	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	5.27e-05	0.000184	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.86e-05	0.00017	CbGpPWpGaD
